Zecotek Announces Appointment of New Independent Director
Singapore, October 14, 2010 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced it has appointed Dr. Jalil Ali to its Board of Directors. Dr. Ali will fill the role of independent director, advising on industry trends as well as providing additional industry expertise at the Board level.
“We are very fortunate to welcome Dr. Jalil Ali to our Board of Directors,” said Dr. A. F. Zerrouk, Chairman, President, and CEO of Zecotek. “Dr. Ali is a recognized expert in his field and we anticipate he will make a significant contribution, in particular as we are at the critical stage of bringing our MAPD devices into mass production. As the Head of Malaysia’s Institute of Photonics and Nanotechnology, with deep connections in the regional semiconductor industry, he will add significant value in transactions with local manufactures and markets. Dr. Ali also has extensive experience leading technology innovation and he will play the role of an independent director, advising on industry trends as well as balancing our expertise at the Board level.”
Dr. Jalil Ali received his PhD in plasma physics from Universiti Teknologi Malaysia (UTM), in 1990. At present, he is Professor of Photonics at the Institute of Advanced Photonics Science, Nanotechnology Research Alliance and the Physics Department, UTM. From 1987-2010, he has held numerous faculty and research positions including the Dean/Director, Bureau of Innovation and Consultancy, UTM. He was instrumental in establishing and forging university-industry collaborations in Malaysia. He has authored/coauthored more than 300 technical papers published in international journals, three books and a number of book chapters. His areas of interests are in photonics, optical solutions, fiber couplers, and nano waveguides. Dr. Jalil Ali is a member of OSA, SPIE, and the Malaysian Institute of Physics.
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing leading-edge products: crystals, photo detectors, lasers, imaging and 3D display technologies, for medical, biotech, industrial, nanotech and atomic/molecular science applications. Founded in 2003, the company has three distinct operating divisions: Laser Systems, Imaging Systems and 3D Display Systems and labs located in Canada, the United States, Singapore, Malaysia and Russia. Zecotek commercializes its novel, patented and patent-pending photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders. For more information, please visit www.zecotek.com.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For Additional Information Please Contact:
Zecotek Photonics Inc.
T: (604) 827-5212
CHF Investor Relations
Christopher Haldane, Account Manager
T: (416) 868-1079 x237
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.